agammaglobulinemia/headache

Lyen an sove nan clipboard la

AtikEsè klinikPatant

Chwazi kalite sòt

12 rezilta yo

A case of hypogammaglobulinemia with enteroviral meningoencephalitis, associated with increased adenosine deaminase in cerebrospinal fluid.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We describe the development of enterovirus meningoencephalitis associated with increased adenosine deaminase in cerebrospinal fluid of a 12-year-old boy, a known case of hypogamaglobulinemia despite monthly replacement of IVIg.The patient was referred to our center with fever, headache and vomiting

[Case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We reported a case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain and lungs. A 21-year-old man was admitted because of one month history of low grade fever, headache, nausea, and amnesia. He developed agammaglobulinemia following Epstein-Barr virus

Pneumococcal meningitis in a young adult female with common variable immunodeficiency.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

METHODS Female, 22 FINAL DIAGNOSIS: Pneumococcal meningitis Symptoms: Fever • headache • neck stiffness • nuchal rigidity • photophobia METHODS Ceftriaxone Clinical Procedure: - Specialty: Neurology. OBJECTIVE Rare disease. BACKGROUND Common variable immunodeficiency (CVID) is a primary

Intravenous immunoglobulin in immunodeficiency states: state of the art.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Intravenous immunoglobulin (IVIg) has been used successfully for hypogammaglobulinemic states for more than 20 yr. In both primary and secondary situations when hypogammaglobulinemia is of clinical significance, IVIg should be the first line of treatment. In most cases, 400 mg/kg infused every 3 to

Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Infectious complications represent a major cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL). The etiology is postulated to be secondary to aberrations in cell-mediated immunity, as well as to therapy-related immunosuppression. Hypogammaglobulinemia,

Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Although long-term intravenous immunoglobulin infusion is an effective treatment for children with antibody deficiencies, it can be complicated by systemic adverse reactions. OBJECTIVE To evaluate the adverse reactions of intravenous immunoglobulin therapy in patients with primary

Adverse effects of intravenous immunoglobulin therapy in patients with antibody deficiency.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Long-term intravenous immunoglobulin (IVIG) infusion is an effective treatment for children with humoral immunodeficiencies, already be complicated by systemic adverse effects. In order to determine the adverse effects of intravenous immunoglobulin in patients with antibody deficiency, 45

A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This multicentre, open-label, prospective, single-arm study was designed to evaluate the efficacy, pharmacokinetics, and safety of IqYmune®, a highly purified 10% polyvalent immunoglobulin preparation for intravenous administration in patients with primary immunodeficiency. IqYmune® was administered

Intra cranial granulomatous disease in common variable immunodeficiency: Case series and review of the literature.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Common variable immunodeficiency (CVID) is typically characterized by hypogammaglobulinemia and often but not always recurrent infections. Paradoxically, 8-22% of patients with CVID develop granulomatous disease. Granulomata have been described in many organs including the lungs, skin, liver,

Herpes simplex virus type 2 meningitis as a manifestation of Good's syndrome.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Good's syndrome is a primary immunodeficiency phenocopy characterized for thymoma and immunodeficiency. The most frequent clinical presentation is recurrent or opportunistic infections, hematological alterations, and chronic diarrhea. We treated a 66-year-old man who consulted for 5 days of headache

Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Intravenous immunoglobulin (IVIG) is increasingly recommended for many diseases apart from primary immunodeficiency diseases (PID). Although effective and safe, adverse reactions may occur. We conducted a 2-year prospective observational study in 117 patients with PID who received regular IVIG

Chronic enteroviral meningoencephalitis in agammaglobulinemic patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Patients with agammaglobulinemia are particularly susceptible to chronic enteroviral infections of the central nervous system. Data on 42 patients were obtained by literature review, communications with other physicians, and personal experiences. Thirty-eight patients had congenital

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye